MENU
NCNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NuCana (NCNA) Ownership - Who owns NuCana?
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
3 Lochside Way
Phone
+44 1313571111
Employees
28
Web
https://www.nucana.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.73M
P/E Ratio
N/A
Total Cash
11.35M
Projected Growth
N/A
Total Debt
221K
Revenue
N/A
Risk (Beta)
2.69
Dividend Yield
N/A
Total Cash/Share
1.87
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NCNA
Capitalization
4.73M
P/E Ratio
N/A
Risk (Beta)
2.69
Dividend Yield
N/A
Total Cash
11.4M
Total Cash/Share
1.87
Total Debt
221K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
4.35M
P/B Ratio
0.60
Cash Flow
N/A
Earnings
-11.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.95M
Current Ratio
1.12
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-29.33M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-97.19
Shares Held By Institutions
496K
Shares Outstanding - Current
6.06M
Total Liabilities
15.2M
Total Volume MTD
N/A
Value
1
Gain YTD
-25.210
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel anti-cancer medicines
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
3 Lochside Way
Phone
+44 1313571111
Employees
28
Web
https://www.nucana.com